National Comprehensive Cancer Network



Educational Events & Programs

NCCN Oncology Research Best Practices Conference™

Space is limited – Register Now!

Educational Events and Resources
Oncology Research Best Practices Conference
October 26 – 27, 2009

Program Location
Bethesda Marriott
5151 Pooks Hill Road
Bethesda, Maryland

Program Overview
The NCCN Oncology Research Best Practices Conference will be a two-day conference focusing on educating participants in the regulatory aspects of research and identifying areas in the clinical trial process where improvements can be made. This conference is designed to be interactive through the use of panel discussions and smaller breakout sessions. Ample opportunities will exist for attendees to network with peers and get important questions and concerns addressed throughout the entire two-day conference.


Program Objectives

  • Identify best practices for improving the operational processes related to conducting oncology research including contracting, budgeting, resource allocation, adverse event reporting. benchmarking, and data management and monitoring
  • Identify best practices for maintaining and improving regulatory compliance in oncology research on federal, state, and local levels
  • Promote dialogue to generate tools and resources to improve oncology research processes

Target Audience
This two-day program is designed to meet the needs of oncology researchers, research nurses, institutional review board professionals, research administrators, academics, ethicists, government regulators, and industry sponsors.


Program Agenda – Monday, October 26, 2009

7:30 AM Registration and Continental Breakfast
8:30 8:50 AM Welcome and Conference Overview
Maurie Markman, MD
The University of Texas
MD Anderson Cancer Center
8:55 9:25 AM Keynote Address: Major Issues in Conducting Clinical Trials

Mark Barnes, JD
Huron Consulting Group, Inc.

9:30 10:30 AM Plenary Session: Intellectual Property Issues

Wesley D. Blakeslee, JD
Johns Hopkins University

10:35 10:50 AM Break
10:55 AM 12:55 PM Panel Discussion: Budget, Billing, and Reimbursement Issues

Moderator:
Clifford Goodman, PhD
The Lewin Group

Panel:
Alice MacDermott, JD
University of Michigan

Ryan D. Meade, JD
Meade & Roach, LLP

Paul Papagni, JD, CIP
The University of Texas
MD Anderson Cancer Center

1:00 1:55 PM Lunch
2:00 3:25 PM

Interactive Breakout Workshops

Biospecimens, Biorepositories, & Molecular Annotation Best Practices
Donald A. Bergstrom, MD, PhD
Merck & Co., Inc.

Carolyn Compton, MD, PhD
National Cancer Institute

Peter Shaw, PhD
Merck & Co., Inc.

Issues in the Ethical Conduct of International and Multi-Institutional Research
Edward Bartlett, PhD
Office for Human Research Protection

Best Practices in Contracting
Raymond T. Rufer , MBA, JD
The University of Texas MD Anderson Cancer Center

3:30 PM Adjourn

 

Program Agenda – Tuesday, October 27, 2009

7:00 AM

Registration and Continental Breakfast

8:00 10:00 AM Panel Discussion: Comparative Effectiveness

Moderator:
William T. McGivney, PhD
National Comprehensive Cancer Network

Panel:
Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Kimary Kulig, PhD
Pfizer, Inc.

Robert S. McDonough, MD, JD, MPP
Aetna

10:05 11:05 AM Plenary Session: Process Improvement for Clinical Trials Operations with an Emphasis on Trial Start-Up

Jeffrey W. Clark, MD (tentative)
Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

11:10 11:25 AM Break
11:30 AM 1:30 PM Panel Discussion: Conflicts of Interest in Clinical Research

Moderator:
Maurie Markman, MD
The University of Texas MD Anderson Cancer Center

Panel:
Robert A. Figlin, MD
City of Hope Comprehensive Cancer Center

Daniel F. Donovan III, JD
King & Spalding

Edward B Goldman, JD
University of Michigan

Gerald H. Sokol, MD, MSc
Food and Drug Administration

1:35 2:30 PM Lunch
2:35 4:00 PM

Interactive Breakout Workshops

Management of Serious Adverse Events
Kristin Bialobok, MSN, RN, CCRC, CCRA
Oregon Health & Science University Knight Cancer Institute

Biospecimens, Biorepositories, & Molecular Annotation Best Practices
Donald A. Bergstrom, MD, PhD
Merck & Co., Inc.

Carolyn Compton, MD, PhD
National Cancer Institute

Peter Shaw, PhD
Merck & Co., Inc.

Issues Related to Incorporating Novel Imaging in Clinical Trials
4:05 PM Adjourn

Agenda and faculty are subject to change.


Registration Fees
$295 – Regular Rate
$195 – NCCN Corporate Council Members
$95 – Government Employee Rate

Space is limited – Register Now!


Supporters
This Conference is supported by grants from Amgen, Millennium: The Takeda Oncology Company and sanofi-aventis, US.


Cancellation Policy
If you register for the conference and then cannot attend, a substitute attendee may be sent in your place. A $50 administration fee will be charged for each substitution. A $50 administration fee will be charged for cancellations received through October 16, 2009. After October 16, the registration fee is not refundable. This cancellation policy pertains only to conference registration.


Accommodations
NCCN has reserved a block of rooms for the evenings of October 25 and October 26 at the rate of $159, plus taxes per night, for this event at the Marriott Bethesda. Please call 800.228.9290 or 301.897.9400 to make your reservation by Friday, October 2, 2009 indicating that you are with the National Comprehensive Cancer Network (NCCN) group. NCCN has no control over hotel policy regarding transfer and cancellation policies. Please clarify all restrictions and policies at time of booking with the hotel agent.